Einstein Researchers Engineer Self-Renewing "Living Drugs" to Prevent Cancer Relapse and Suppress HIV Reservoirs

Einstein researchers develop a cytokine-fusion scaffold to engineer long-lasting CAR T cells that prevent cancer relapse and suppress HIV.

By: AXL Media

Published: Mar 14, 2026, 11:34 AM EDT

Source: Information for this report was sourced from Albert Einstein College of Medicine

Addressing the Persistence Bottleneck in Immunotherapy

The field of regenerative medicine has long sought to transform CAR T-cell therapy from a temporary intervention into a permanent internal defense system. According to researchers at the Albert Einstein College of Medicine, the primary obstacle to long-term success has been the rapid exhaustion of engineered cells once they are infused into the patient. While current treatments often achieve initial remission, the potency of these "guided missiles" frequently wanes, leading to disease relapse in approximately half of all cancer patients. This new research, published in Science Advances, introduces a manufacturing shift designed to create a "living drug" capable of patrolling the body for years.

The Role of T Memory Stem Cells in Long-Term Defense

To solve the durability crisis, the team focused on a rare and highly effective population of immune cells known as T memory stem cells. According to senior author Dr. Harris Goldstein, these cells are critical for immune persistence because they can self-renew and continually replenish the supply of active killers. The study reveals that a new production method allows more than 50% of the resulting CAR T cells to adopt this stem-like profile. In contrast, conventional manufacturing methods typically yield a population where less than 5% of the cells possess these essential long-lived attributes.

A Multi-Cytokine Scaffold for Enhanced Cellular Fitness

The breakthrough was made possible by the development of a protein scaffold called HCW9206, which serves as a biological bridge for immune signaling. According to the research, this scaffold links three naturally occurring cytokines—IL-7, IL-15, and IL-21—which are known to promote cellular survival and memory. By using this multi-protein fusion during the manufacturing process, the scientists were able to reprogram the T cells more effectively than standard activation protocols, resulting in a cellular product that is both a powerful killer and an enduring guardian.